eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools   Community
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Ask question       Write review       Answered/ Unanswered       Reviews       WellConnected

From FDA reports: drug interactions between Tarivid Otic Solution Ofloxacin, Augmentin '125' for a Male patient aged 34

This is a personalized study for a 34 year old male patient. The study is created by eHealthMe based on reports of 270 people who take the same drugs and have drug interactionsfrom FDA.

On Nov, 11, 2014: 270 people who reported to have interactions when taking Tarivid Otic Solution Ofloxacin, Augmentin '125' are studied

Trend of Tarivid  Otic Solution   Ofloxacin, Augmentin '125''s drug interactions, side effects, and effectiveness reports (1258593)

Information of the patient in this study:

Age: 34

Gender: male

Conditions: Ear Infection

Drugs taking:
- Tarivid Otic Solution Ofloxacin
- Augmentin '125': used for < 1 month
- Augmentin '125': used for < 1 month

Drug interactions have: Anaemia Macrocytic

eHealthMe real world results:

Comparison with this patient's adverse outcomes among males aged 34 (±5):

InteractionNumber of reports
Anaemia Macrocytic (a macrocytic class of anaemia)2 (33.33%)

Most common interactions experienced by males aged 34 (±5) in the use of Tarivid Otic Solution Ofloxacin, Augmentin '125':

InteractionNumber of reports
Bronchitis Nos4
Anaemia Nos4
Eosinophilia (eosinophil count in the peripheral blood exceeds)2
Dermatitis Exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)2
Transaminases Increased2
Skin Test Positive2
Coagulation Factor Viii Level Decreased2
Postoperative Complications Nos2
Pyrexia (fever)2
Ear Infection (ear infection)2

Most common interactions experienced by males aged 34 (±5) in long term use of Tarivid Otic Solution Ofloxacin, Augmentin '125':

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Anaemia Macrocytic (a macrocytic class of anaemia)2 (0.74%)

Most common interactions experienced by people in the use of Tarivid Otic Solution Ofloxacin, Augmentin '125':

InteractionNumber of reports
Pyrexia (fever)83
Renal Failure Acute (rapid kidney dysfunction)46
Drug Interaction42
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)41
Thrombocytopenia (decrease of platelets in blood)40
Confusional State34
Pleural Effusion (water on the lungs)32
Condition Aggravated (worse condition)32
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)32
Atrial Fibrillation (fibrillation of the muscles of the atria of the heart)26

Most common interactions experienced by people in long term use of Tarivid Otic Solution Ofloxacin, Augmentin '125':

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.